The 6-h plasma profiles of adrenocorticotropic hormone (ACTH), cortisol, a-melanocyte-stimulating hormone (a-MSH), and GH were studied in 17 dogs with pituitarydependent hyperadrenocorticism (PDH) before and after hypophysectomy. The aim of the study was to investigate the relation between the hormone profile characteristics and recurrence of PDH after surgery.
Introduction
Pituitary-dependent hyperadrenocorticism (PDH) is a common spontaneous endocrine disorder in dogs, which shows many similarities with Cushing's disease in humans (Kemppainen & Peterson 1994) . As in humans with Cushing's disease (Lamberts 2002 , Reimondo et al. 2003 , PDH in dogs is characterized by adrenocorticotropic hormone (ACTH)-induced hypercortisolism and reduced sensitivity to glucocorticoid feedback inhibition (Rijnberk et al. 1988a , Bosje et al. 2002 , in most cases with preserved ability to respond to corticotrophin-releasing hormone (CRH) stimulation (Meij et al. 1997b , Reimondo et al. 2003 . The excessive pituitary secretion of ACTH originates from a corticotropic adenoma in the pars distalis or the pars intermedia of the adenohypophysis. PDH caused by an adenoma in pars intermedia is often characterized by highly elevated plasma concentrations of a-melanocyte-stimulating hormone (a-MSH) and strong resistance to dexamethasone suppression (Peterson et al. 1986 , Rijnberk et al. 1988b , Bosje et al. 2002 . In Cushing's disease, there are not only alterations in ACTH secretions but also in the secretion of other pituitary hormones (van den Berg et al. 1997 , Roelfsema et al. 1998 , Veldman et al. 2000 . In dogs with PDH, these changes may include basal levels, response to stimulation (Meij et al. 1997b) , as well as the pulsatile release pattern that is characteristic of pituitary hormone secretion (Kemppainen & Sartin 1984 , Brabant et al. 1992 , Kooistra et al. 1997a , Kooistra & Okkens 2001 , Corrada et al. 2003 , Lee et al. 2003 . For example, plasma growth hormone (GH) concentration and its responsiveness to stimulation with GH-releasing hormone (GHRH) have been reported to be decreased in dogs with PDH, most likely due to glucocorticoid-induced alterations in the function of pituitary somatotropic cells and changes in suprapituitary regulation (Meij et al. 1997b ). In addition, canine PDH is associated with less GH secreted in pulses than in controls (Lee et al. 2003) .
Pituitary surgery is the treatment of choice in humans with Cushing's disease (Rees et al. 2002) . Preferably, an adenomectomy is performed, but 15-26% of the cases undergo a total hypophysectomy (Barker et al. 2003) . Transsphenoidal hypophysectomy is an effective treatment in dogs with PDH (Meij et al. 1998) . In both species, recurrence of the disease is a serious problem. In a study on 150 dogs with PDH, the fraction that relapsed within 2 years after hypophysectomy was 25% (Hanson et al. 2005) . In humans, the recurrence rate is 5-30% after pituitary surgery for corticotropic adenomas (Rees et al. 2002 , Pereira et al. 2003 .
After transsphenoidal hypophysectomy in healthy dogs, residual pituitary cells have been observed in the pituitary fossa (Niebauer et al. 1990 , Meij et al. 1997d , Axlund et al. 2005 . Such cells are devoid of the direct influence of the hypothalamus due to section of the pituitary stalk. Upon administration of secretagogs, the residual corticotropic cells appeared functional. They secreted ACTH after stimulation with CRH (Meij et al. 1997a) . Stimulation with other secretagogs, e.g. thyroptropin-releasing hormone (TRH), GHRH, and gonadotropin-releasing hormone (GnRH), evoked no adenohypophyseal hormone secretion (Meij et al. 1997d) . Eight weeks after surgery, the CRH stimulation test was not able to identify the dogs that would later relapse (Meij et al. 1997a) . The pulsatile secretion pattern of remnant pituitary cells has not yet been studied. It was hypothesized that the secretion pattern would differ between remnant adenomatous and normal corticotropic cells and that the profile characteristics after hypophysectomy would hold predictive value for recurrence of hyperadrenocorticism.
Here, we report on the 6-h plasma profiles of ACTH, cortisol, a-MSH, and GH in dogs with PDH before and after transsphenoidal hypophysectomy. The aim of the study was to investigate the relation between the hormone profile characteristics and recurrence of PDH after surgery.
Materials and Methods

Animals, diagnosis, and treatment of PDH
Seventeen dogs of different breeds with PDH were included in the study. The group comprised two Miniature Poodles, one Dachshund, one Basset Fauve de Bretagne, one Cairn Terrier, one English Cocker Spaniel, one Pitt Bullterrier, one Shetland Sheepdog, one Soft Coated Wheaten Terrier, one Standard Poodle, one Welsh Corgi and six cross-bred dogs. There were 6 females (2 spayed) and 11 males (2 castrated) with a median age of 8 years (range 5-12 years), and a median body weight of 15 kg (range 7-27 kg).
The diagnosis of hyperadrenocorticism was based upon averaged urinary corticoid-to-creatinine ratios (UCCR) in two consecutive morning urine samples. In all animals, the UCCRs (median, 44!10 K6 ; range, 23-321!10 K6 ) exceeded the ratios found in 87 healthy companion dogs (range 0$3-8$3!10
K6
; van Vonderen et al. 1997) . After collection of the second urine sample, three oral doses of 0$1 mg dexamethasone per kilogram body weight were administered at intervals of 8 h. In 13 cases, the UCCR in the third sample was less than 50% of the mean of the first two samples and PDH was diagnosed (Galac et al. 1997) . In four cases, with less than 50% suppression of the third UCCR, pituitary dependency was secured by measurements of plasma ACTH concentrations and further supported by visualization of the adrenals by ultrasonography and by pituitary imaging with computed tomography (CT; Rijnberk et al. 1987 , Bosje et al. 2002 , van der Vlugt-Meijer et al. 2002 .
Transsphenoidal hypophysectomy was performed according to a microsurgical technique described previously (Meij et al. 1997c) . Postoperative care and hormone supplementation were according to previously published protocols (Meij et al. 1997c , 1998 , Hanson et al. 2005 . Briefly, hydrocortisone and desmopressin were directly administrated after the removal of the pituitary gland. When the dogs had resumed drinking and eating, oral substitution therapy was started with cortisone acetate and thyroxin. The dose of cortisone acetate was gradually lowered over a period of 4 weeks to a physiological dose. Desmopressin was administered for 2 weeks routinely and continued if polyuria due to central diabetes insipidus persisted.
Re-examination after 8 weeks included physical examination, routine blood chemistry, measurements of basal plasma thyroxine concentration at 10-12 h after L-thyroxine medication, and basal UCCR in duplicate at 24 h after cortisone medication (median 1$7!10
; range 0$3-5$2! 10
). UCCRs were measured again half a year after surgery and thereafter once a year. In case of suspicion of recurrence, UCCRs were determined earlier. Urine samples were mailed to our laboratory and follow-up reports were obtained from the above-mentioned routine follow-up examinations in the hospital and during telephone conversations with the owner and/or the referring veterinarian.
There was one case of early postoperative mortality (within 4 weeks) due to kidney failure. In all 16 remaining dogs, there was remission: UCCR !10!10 K6 and resolution of clinical signs of hyperadrenocorticism. Recurrence was defined as UCCR R10!10 K6 and/or return of signs and symptoms of hyperadrenocorticism after initial complete remission. This occurred in 9 out of the 16 cases after median 652 days (range 201-1679 days).
Control dogs for pulsatile secretion
The plasma profiles of cortisol, ACTH, and a-MSH of the PDH cases were compared with those obtained in eight healthy beagle dogs (four intact females and four intact males, with body weight ranging from 12 to 25 kg, and age ranging from 2 to 5 years; Kooistra et al. 1997a) . The plasma GH profiles of the PDH cases were compared with those of plasma obtained from six healthy female beagle dogs (with body weight ranging from 12 to 27 kg, and age ranging from 7 to 9 years; Lee et al. 2003) .
Sample collection for pulsatile plasma profile
In the PDH dogs, the 6-h plasma hormone profiles were determined 2-34 days (median, 8 days) before surgery and 50-133 days (median, 71 days) after hypophysectomy. Preoperative 6-h plasma profiles of ACTH and cortisol were available from 17 cases, a-MSH from 14 cases, and GH from 14 cases. After hypophysectomy, 6-h plasma profiles of ACTH and cortisol became available from 14 cases, a-MSH from 13 cases, and GH from 11 cases.
Food, but not water, was withheld from the animals 12 h prior to blood sampling. Blood samples (4 ml) were collected from the jugular vein by an experienced technician at 10-min intervals between 0800 and 1400 h. Blood was collected in pre-chilled EDTA-coated tubes on ice and centrifuged at 4 8C (2000 g, 10 min). Plasma was stored at K20 8 C until assayed.
This study on the pulsatile secretion was approved by the Ethical Committee of Utrecht University and for the PDH dogs informed consent was obtained from the owners.
Hormone determinations
Plasma ACTH concentration was measured using a commercially available two-site immunoradiometreic assay (IRMA; Nichols Institute, Wijchen, The Netherlands). The antiserum was highly specific for ACTH (1-39). A polyclonal antibody was bound specifically to the C-terminal region of ACTH. The radioiodinated monoclonal antibody was bound only to the N-terminal region of ACTH. The intra-assay coefficient of variation (CV) was 3$2%, the inter-assay CV was 7$8%, and the sensitivity was 0$22 pmol/l. There was no crossreaction between the antiserum and a-MSH or ACTH precursors (Raff & Findling 1989 , Bosje et al. 2002 .
Plasma cortisol concentration was measured with a solid phase 125 I RIA; Coat-A-Count Cortisol, Diagnostic Products Corporation, Los Angeles, CA, USA. The antiserum was highly specific for cortisol, with very low cross-reactivity to other compounds that were present in patient samples. Proteins, bilirubin, lipemia, and hemolysis had no significant effect on the assay. The intra-assay CV was 4$5-6$3%, the inter-assay CV, 4%, and the sensitivity, 5$5 nmol/l.
The urinary corticoid concentration was measured with RIA as described previously (Rijnberk et al. 1988a) . The intra-assay CV was 6%, the inter-assay CV, 8%, and the sensitivity, 1 nmol/l. The urinary corticoid concentration was related to the urinary creatinine concentration (Jaffé kinetic method, initial rate reaction) and the UCCR calculated (Stolp et al. 1983 , Rijnberk et al. 1988a .
Plasma concentration of a-MSH was measured with RIA without extraction as described previously (Rijnberk et al. 1988b) . The intra-assay CV was 10%, the inter-assay CV, 23%, and the sensitivity, 3 pmol/l. The antiserum had less than 0$1% cross-reactivity with ACTH (1-39) and 4% crossreactivity with ACTH (1-24).
Plasma GH concentration was measured by a homologous RIA as described previously (Eigenmann & Eigenmann 1981) . The intra-assay CV was 3$8%, the inter-assay CV, 7$2%, and the sensitivity, 0$3 mg/l. The degree of crossreaction of canine prolactin was 2%.
Statistical analysis
The 6-h plasma hormone profiles were analyzed using the Pulsar program developed by Merriam & Wachter (1982) . The program identifies secretory peaks by height and duration from a smoothed baseline, using the assay S.D. as a scale factor. The cut-off parameters G1-G5 of the Pulsar program were set at 3$98, 2$4, 1$68, 1$24, and 0$93 times the assay S.D. as criteria for accepting peaks 1, 2, 3, 4, and 5 points wide. The smoothing time, a window used to calculate a running mean value, was set at 5 h. The weight assigned to peaks was 0$05. The A, B, and C values of the Pulsar program used to calculate the variance of the assay was set at AZ0, BZ7$1, and CZ32 for ACTH; AZ0, BZ4$8, and CZ114 for cortisol; AZ0, BZK2$44, and CZ451 for a-MSH; and AZ0, BZ7$2, and CZ5 for GH. The values extracted from the Pulsar analyses included the overall mean of the smoothed baseline, area under the curve (AUC) above the zero level, and the number of significant pulses per 6 h.
The differences in variables between control dogs and dogs with PDH were assessed by the non-parametric MannWhitney test (with Bonferroni correction). The differences in variables before and after surgery were assessed by Wilcoxonsigned ranks test for related samples (with Bonferroni correction). A P!0$05 was considered significant. Fishers's exact test was used to analyze the co-occurrence of significant ACTH, cortisol, and a-MSH pulses.
Univariate Cox proportional hazard fit analyses were performed using Newton-Raphson algorithm for the disease-free period on the characteristics of the plasma hormone profiles (mean of the smoothed baseline, AUC, pulse frequency) for ACTH, cortisol, a-MSH, and GH before and after hypophysectomy.
Results
All four hormones were secreted in a pulsatile fashion in control dogs as well as in dogs with PDH ( Fig. 1a and b) . Representative graphs of the plasma profiles for the controls have been published previously (Kooistra et al. 1997a , Lee et al. 2003 .
ACTH and cortisol
In the dogs with PDH, the basal plasma cortisol concentration (P!0$005) and the AUC for cortisol (P!0$001) were significantly higher than those in the controls. There was no significant difference in the cortisol pulse frequency. After hypophysectomy, the basal plasma cortisol concentration (P!0$005), the AUC for cortisol (P!0$005), and the cortisol pulse frequency (P!0$005) decreased significantly (Fig. 2) . The basal plasma ACTH concentration, the AUC for ACTH, and the ACTH pulse frequency in the PDH dogs were not significantly different from those in the controls. Significant ACTH pulses were identified by the Pulsar program in 14 out of the 17 dogs with PDH. After surgery, the AUC for ACTH (P!0$05) and the ACTH pulse frequency (P!0$05) decreased significantly, whereas the basal plasma ACTH concentration tended to decrease (PZ0$052) (Fig. 2) . Significant ACTH pulses were identified in 10 out of the 14 cases after hypophysectomy; 8 of these 10 dogs had a recurrence later. Significant ACTH pulses were absent in 4 out of the 14 cases and 3 of these 4 dogs remained in remission.
In the PDH dogs and in the controls, the majority of ACTH pulses coincided with cortisol pulses. In the controls, 23 out of 26 significant ACTH pulses identified by the Pulsar program coincided with 21 out of 38 significant cortisol pulses. In the PDH cases, 32 out of 36 significant ACTH pulses coincided with 32 out of 65 significant cortisol pulses. The difference between co-occurrence of ACTH and cortisol pulses in control and PDH cases was not significant. After surgery, 5 out of 12 significant ACTH pulses coincided with 5 out of 26 significant cortisol pulses. The difference between co-occurrence of ACTH and cortisol pulses before and after surgery was significant (P!0$01).
a-MSH
The basal plasma a-MSH concentration, the AUC for a-MSH, and the a-MSH pulse frequency in the PDH cases were similar to those in the controls. Significant a-MSH pulses were identified in 7 out of the 14 PDH cases. After hypophysectomy, no significant a-MSH pulses were detected in any of the dogs. In one dog with dexamethasone-resistant Figure 1 The plasma profiles of ACTH, cortisol, a-MSH, and GH before and after hypophysectomy (HX) in (a) a representative dog with pituitary-dependent hyperadrenocorticism (PDH), and (b) a dog with PDH with markedly elevated plasma a-MSH concentrations before hypophysectomy (note the difference in scale of the y-axis 1b). Blood samples were collected at 10-min intervals for 6 h. *Peaks identified by the Pulsar programme. Figure 2 Box-plot graphs (median, interquartile and total range) for the basal plasma hormone concentration, the area under the curve (AUC), and the pulse frequency of ACTH, cortisol, a-MSH and GH in control dogs and in dogs with pituitary-dependent hyperadrenocorticism (PDH) before and 2-4 months after hypophysectomy (HX). Blood samples were collected at 10-min intervals for 6 h. Outliers are indicated with circles; extreme values with triangles. For values that are off scale the actual value is given within brackets. Significant differences between groups are indicated with asterices above the boxplots. Asterices above the boxes for PDH dogs before HX indicate differences compared with the control dogs and asterices above the boxes for PDH dogs after HX indicate differences compared with PDH dogs before HX; * P!0$05; † P!0$01; ‡ P!0$001. PDH, a very high basal plasma a-MSH concentration (215 pmol/l; reference range %36 pmol/l (Kooistra et al. 1997b , Bosje et al. 2002 ) was found and 12 significant a-MSH pulses identified (Fig. 1b) . In this case, the postoperative basal a-MSH concentration was 4$5 pmol/l (Fig. 1b) .
In the PDH dogs and in the controls a-MSH pulses frequently coincided with ACTH pulses. In the controls, 3 out of 4 significant a-MSH pulses coincided with significant ACTH pulses, whereas in the PDH cases, 9 out of 25 significant a-MSH pulses coincided with significant ACTH pulses. In the dog with 12 significant a-MSH pulses, only 3 (high) a-MSH pulses coincided with a significant ACTH pulse (Fig. 1b) . In some cases, an a-MSH pulse preceded an ACTH pulse.
GH
The basal plasma GH concentration, the AUC for GH, and the GH pulse frequency were not significantly different between controls and PDH dogs, and also not between the PDH cases before and after hypophysectomy. Significant GH pulses were detected in 11 out of 15 dogs with PDH. After hypophysectomy, significant GH pulses were detected in 8 out of the 11 PDH cases.
Disease-free period and identification of risk parameters
The median disease-free period was 880 days (95% CI, 732-1028 days). The 1-year disease-free fraction was 87% (95% CI, 56-96%) and the 2-year disease-free fraction, 65% (95% CI, 35-84%). In 9 out of the 16 cases, hyperadrenocorticism recurred after 1$5-5$5 years. In the univariate Cox proportional hazard analysis, there was no association between preoperative hormone values and recurrence of hyperadrenocorticism. Of the values after hypophysectomy, the ACTH pulse frequency was associated with a significant (P!0$05) higher risk for recurrence of hyperadrenocorticism (hazard ratio 5$357; 95% CI, 1$003-28$611). A higher AUC for GH after surgery tended to be associated with a lower risk of recurrence (PZ0$076; hazard ratio 0$768, 95% CI, 0$553-1$066).
Discussion
The results of this study demonstrate that the pulsatile nature of the pituitary hormone release is maintained in pituitarydependent hyperadrenocorticism. Significant pulses of ACTH (and consequently cortisol), a-MSH, and GH were identified in the plasma profiles of dogs with PDH. Interestingly, significant pulses were also observed in some of the cases in remission after hypophysectomy. The presence of significant ACTH pulses after surgery was identified as a risk factor for recurrence of hyperadrenocorticism.
Before surgery, the pulse frequencies of ACTH and cortisol in the PDH cases were not different from those in the controls, which is in agreement with previous reports on dogs (Orth et al. 1988 ) and on humans with Cushing's disease (van den Berg et al. 1995) . In this study, the AUC for ACTH and ACTH pulse frequency decreased after hypophysectomy. In addition, the basal plasma cortisol concentration, the AUC for cortisol, and the cortisol pulse frequency decreased significantly and there was less co-occurrence between ACTH and cortisol pulses after surgery. In accordance with the relatively low values of the plasma profile characteristics for ACTH and cortisol after hypophysectomy, remission was achieved in all 16 dogs that survived the early postoperative period.
In this study, complete hypophysectomy with elimination of all ACTH-producing cells was the surgical goal. Hypophysectomy is consistent with a substantial reduction in the number of corticotropic cells, which leads to remission of hyperadrenocorticism. Nevertheless, there was residual ACTH secretion after hypophysectomy. Corticotropic cells are fairly resistant to elimination and complete removal of the pituitary gland is difficult to achieve (Ganong & Hume 1956 ). Also, in what macroscopically appears to be an empty pituitary fossa, small remnant microscopic islets of pituitary cells capable of hormone production and response to CRH stimulation test have been found after hypophysectomy in both controls and PDH dogs (Niebauer et al. 1990 , Meij et al. 1997a , 1997d , Axlund et al. 2005 . The most likely origin of these cells are remnants from an incompletely removed pars distalis hypophysis (which easily falls apart upon manipulation) or, in the PDH cases, remnant adenomateous corticotropic cells. Less likely, the remnant cells may also originate from differentiated pituitary stem cells or from accessory pituitary tissue that, in the dog, is sporadically found in the dura mater lateral to the pituitary (von Nickel et al. 1992) .
In previous reports, no remnant pituitary cells were identified on the ventral hypothalamic diencephalons in hypophysectomized experimental animals (Meij et al. 1997a , 1997d , Axlund et al. 2005 . Therefore, it can be assumed that the pituitary-hypothalamic portal system is completely impeded and that the residual hormone secretion activity measured in this study originates from the microscopic islets in the pituitary fossa. Interestingly, the residual ACTH secretion was pulsatile in character. It is possible that this could be due to the influence of CRH, to which the corticotropic cells in the pituitary residual islets are able to respond (Meij et al. 1997a (Meij et al. , 1997d , reaching the pituitary cells on an alternative vascular route or through the cerebrospinal fluid from the opened third ventricle after hypophysectomy. The residual pulsatile ACTH secretion after hypophysectomy may also be explained by intrinsic ACTH pulsatility (Gambacciani et al. 1987) , by release of vasopressin from the hypothalamus or by CRH-independent secretory capacity of corticotropic cells (Fukuda et al. 2004) .
In agreement with earlier observations (Orth et al. 1988 , Kooistra et al. 1997a ), a-MSH was secreted in a pulsatile fashion in both the controls and the PDH dogs. Under basal conditions, the pars intermedia of the canine adenohypophysis is under strong and almost permanent dopaminergic inhibition (Peterson et al. 1986 , Kemppainen & Sartin 1988 , Orth et al. 1988 , Meij et al. 1997d ). The significant a-MSH pulses are probably the result of a temporary decrease in the tonic hypothalamic dopaminergic inhibitory control. The administration of a dopamine antagonist such as haloperidol results in a significant release of a-MSH (Orth et al. 1988 , Kooistra et al. 1997a .
The a-MSH pulsatility was similar in the PDH dogs and the controls. After hypophysectomy, there were no a-MSH pulses. This is compatible with complete removal of the neurointermediate lobe. In a previous study on pituitary function after hypophysectomy in experimental animals, administration of the dopamine-antagonist haloperidol caused no elevation of the basal plasma a-MSH concentration, whereas before surgery there was a 30-fold increase (Meij et al. 1997d) .
Several a-MSH pulses co-occurred with ACTH pulses that is explained by co-release of ACTH and a-MSH from the pars intermedia (Kooistra et al. 1997a ) by the same secretagog or stimulatory event. Previous studies demonstrated that the dopamine-antagonist haloperidol increases the plasma concentrations of both a-MSH and ACTH (Kemppainen & Sartin 1988 , Kooistra et al. 1997a . The haloperidolstimulated secretion of a-MSH reached its maximum value within 10 min, whereas the haloperidol-stimulated secretion of ACTH reached its maximum value after 60 min. Therefore, an a-MSH pulse preceded an ACTH pulse in some cases of the present study.
Dogs with PDH and humans with Cushing's disease secrete less GH in pulses than healthy individuals (Veldman et al. 2000 , Lee et al. 2003 . The same was observed in the present study, although no statistical significance was reached. Sustained exposure to supraphysiological amounts of glucocorticoids inhibits pulsatile GH secretion and blunts the GH response to stimuli mainly by altering the hypothalamic somatostatin tone (Muller et al. 1999) .
In the group of PDH dogs, hypophysectomy caused no further significant decrease in the already low plasma GH concentrations. However, in some individual cases, the decline of the basal GH values was distinct. These findings are in agreement with a previous study in which hypophysectomy led to a significant decrease in the plasma GH concentrations (Meij et al. 1997a) . Plasma GH concentrations unaffected by hypophysectomy are most likely the result of secretion by residual somatotropic cells in the pituitary fossa (Hassan & Merkel 1994 , Meij et al. 1997a , 1997d . Another explanation is the extra-pituitary GH production that occurs in many tissues under both normal and pathologic conditions (Mol et al. 1995 , van Garderen et al. 1997 , Lantinga van Leeuwen et al. 2000 , Harvey et al. 2001 , Robben et al. 2002 , Petterino et al. 2004 ). This extra-pituitary GH is mainly thought to have local autocrine and paracrine effects, but may also reach the systemic circulation. For example, progesterone-induced GH release from the mammary gland during the luteal phase may increase the plasma GH concentration in bitches (Kooistra & Okkens 2002) . However, hypophysectomy removes the FSH-and LHsecreting gonadotropic cells (resulting in permanent anoestrus and a very low plasma progesterone concentration), and therefore, it is unlikely that circulating GH after hypophysectomy is of mammary origin.
There was no association between preoperative characteristics of the plasma hormone profiles and recurrence of hyperadrenocorticism, which is in agreement with the results of a study after transsphenoidal hypophysectomy in humans with Cushing's disease (Buchfelder et al. 1993) . The number of significant ACTH pulses after hypophysectomy, however, was identified as a risk for recurrence of hyperadrenocorticism. Consequently, pulsatile ACTH secretion at 8 weeks after hypophysectomy is more likely to reflect the presence of residual adenomatous than unaffected corticotropic cells in the pituitary fossa. In an earlier study, the CRH-stimulation test 8 weeks after hypophysectomy effectively identified dogs with residual disease but failed to differentiate between the cases that developed recurrence of hyperadrenocorticism and those that remained in remission (Meij et al. 1997a) . Thus, the intrinsic ability of pulsatile hormone release is more informative for the prognosis than the response to CRH stimulation at 8 weeks after hypophysectomy. The slow growth rate of the corticotropic adenoma may explain why hyperadrenocorticism recurs in 1$5-5 years. There was also a tendency that high postoperative AUC for GH was associated with a low risk of recurrence, which may be a reflection of normalized GH secretion of the residual somatotropic cells after successful elimination of inhibition by high cortisol levels.
In conclusion, the results of the present study indicate that in PDH dogs, ACTH, cortisol, a-MSH, and GH are secreted in a pulsatile fashion, and that hypophysectomy effectively reduces the secretion of ACTH and cortisol. The presence of ACTH pulses after hypophysectomy is associated with a higher risk of recurrence of hyperadrenocorticism.
